Polyclonal Antibody to Cancerous Inhibitor Of PP2A (CIP2A) is a premium-quality life science research product supplied by Torvigen for laboratory and scientific applications.
RPR982Hu01-Recombinant Cancerous Inhibitor Of PP2A (CIP2A)
Recommended Usage
Western blotting: 0.01-2μg/mL; < br/> Immunohistochemistry: 5-20μg/mL; < br/> Immunocytochemistry: 5-20μg/mL; < br/> Optimal working dilutions must be determined by end user.
